Portugália is expanding in Macau, targeting Hong Kong, and returning to Hengqin. CEO Francisco Carvalho Martins sees Macau as ...

Hamas on Friday said it was ready to free an Israeli-American hostage and the remains of four other dual nationals, after the Palestinian militants and Israel gathered for indirect Gaza ceasefire ...

Hong Kong and Macau delegates to the country's top political advisory body said the two SARs should make good use of their ...

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMRAMR is a ...

Tu Haiming of China’s top advisory body issues call at meeting amid Beijing’s most important annual political gathering, ...

WHARF REIC Annual Underlying NP Hikes 2% to $6.14B; 2nd Interim DPS $0.6 ...

BIIB's TRANSCEND phase III study on felzartamab in adult kidney transplant recipients diagnosed with late AMR is set to enroll approximately 120 patients.

Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.

Cambridge, Massachusetts Thursday, March 13, 2025, 10:00 Hrs [IST] ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

Hong Kong society lacks a proper understanding of the “one country, two systems” governing principle, only considering it a solution for “historical issues” and unrelated to national ...